ProfileGDS2971 / 5.3.7.17
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 24% 69% 75% 55% 82% 55% 49% 45% 53% 74% 48% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.36500924
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)0.34360369
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 20.39973175
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)0.091527355
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.51597382
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.028536555
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.018548349
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.069447645
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.086635853
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.61769174
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.010086348
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.099451539